甲状腺切除术后甲状腺床病变超声特征在复发癌诊断或排除中的作用
回顾性分析1885例甲状腺切除术后患者共5732次超声检查,40.4%报告甲状腺床病变,其中58.8%最大径≥6mm。仅病变内点状强回声和甲状腺切除时淋巴结阳性史与恶性相关(P<.001)。1303个<6mm病变中仅2个(0.2%)为恶性,<6mm且无点状强回声者恶性风险极低。
要点
- 甲状腺床病变常见(40.4%),但仅4.6%行FNA,其中42.4%为恶性。
- 点状强回声和甲状腺切除时淋巴结阳性史与恶性相关(P<.001)。
- <6mm病变恶性率仅0.2%,<6mm且无点状强回声者恶性风险极低。
关键影像表现/征象
- 5732次超声检查中报告3163个甲状腺床病变(40.4%),其中1860个(58.8%)最大径≥6mm。
- 144个病变(4.6%)行FNA,61个(42.4%)恶性、33个(22.9%)良性、50个(34.7%)无法诊断,5个无法诊断病变最终证实为恶性。
- 恶性病变中点状强回声出现率45.9%(28/61),良性9%(3/33),无法诊断24%(12/50),P<.001。
- 甲状腺切除时淋巴结阳性史在恶性病变中72.1%(44/61),良性30%(10/33),无法诊断38%(19/50),P<.001。
- 未行FNA的3019个病变中3个为恶性;1303个<6mm病变中仅2个(0.2%)为恶性。
诊断标准与关键数值
- 点状强回声与恶性相关:恶性病变45.9%(28/61)vs 良性病变9%(3/33)vs 无法诊断病变24%(12/50),P<.001。
- 甲状腺切除时淋巴结阳性史与恶性相关:恶性病变72.1%(44/61)vs 良性病变30%(10/33)vs 无法诊断病变38%(19/50),P<.001。
- <6mm病变恶性率0.2%(2/1303);<6mm且无点状强回声者恶性风险极低(原文结论)。
临床应用与阅片要点
- 甲状腺床病变常见,多数为良性,尤其<6mm且无点状强回声者恶性风险极低。
- 点状强回声和甲状腺切除时淋巴结阳性史是与恶性相关的超声和临床特征。
- FNA在甲状腺床病变中应用比例低(4.6%),且34.7%无法诊断,5个无法诊断病变最终证实为恶性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background US of the thyroid bed in patients with thyroid cancer often depicts small lesions, but it is unclear whether US characteristics of lesions can help predict cancer recurrence. Purpose To determine whether size or US features of lesions in the thyroid bed after thyroidectomy in conjunction with clinical features can help predict thyroid cancer recurrence. Materials and Methods With use of a US reporting database, all patients imaged between July 2006 and June 2016 with an indication of post-thyroidectomy follow-up were retrospectively identified. Recorded data included patient demographic characteristics; date of thyroidectomy; thyroid cancer type; presence, size, and US characteristics of thyroid bed lesions; and results of fine-needle aspiration (FNA). Images were reviewed for lesions that underwent FNA. The Fisher exact test was used for analysis. Results A total of 1885 patients (mean age ± standard deviation, 48 years ± 15; 1493 female patients) underwent 5732 US examinations. Most patients (1541 of 1885 [82%]) had papillary cancer. Overall, 3163 thyroid bed lesions were reported in 5732 US examinations (40.4%). More than half of these lesions (1860 of 3163 [58.8%]) had a maximum measurement of 6 mm or greater. FNA was performed in 144 of the 3163 lesions (4.6%), of which 61 (42.4%) were malignant, 33 (22.9%) were benign, and 50 (34.7%) were nondiagnostic. Five nondiagnostic lesions eventually proved malignant. Only the presence of punctate echogenicities in the lesion (28 of 61 malignant lesions [45.9%]; three of 33 benign lesions [9%]; 12 of 50 nondiagnostic lesions [24%]; P < .001) or the history of positive lymph nodes at thyroidectomy (44 of 61 malignant lesions [72.1%]; 10 of 33 benign lesions [30%]; 19 of 50 nondiagnostic lesions [38%]; P < .001) were associated with malignancy. Of 3019 thyroid bed lesions that did not undergo FNA, three were malignant and 2248 showed no growth at follow-up US ranging from 6 months to 10 years and are presumed benign. Of the 1303 lesions smaller than 6 mm, only two (0.2%) were malignant. Conclusion Small lesions are commonly found in the thyroid bed after thyroidectomy, and most are likely to be benign. Lesions smaller than 6 mm with no punctate echogenicities had a minimal risk for malignancy. © RSNA, 2021 See also the editorial by Grant and Malhi in this issue.
引用
- Frates MC, Parziale MP, Alexander EK, et al. Role of Sonographic Characteristics of Thyroid Bed Lesions Identified Following Thyroidectomy in the Diagnosis or Exclusion of Recurrent Cancer. Radiology. 2021. PMID: 33650902. doi:10.1148/radiol.2021201596
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。